Manchester Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197K | Hold |
3,000
| – | – | 0.03% | 343 |
|
|
2025
Q1 | $212K | Hold |
3,000
| – | – | 0.03% | 323 |
|
|
2024
Q4 | $197K | Hold |
3,000
| – | – | 0.02% | 334 |
|
|
2024
Q3 | $212K | Hold |
3,000
| – | – | 0.02% | 319 |
|
|
2024
Q2 | $199K | Hold |
3,000
| – | – | 0.02% | 309 |
|
|
2024
Q1 | $204K | Hold |
3,000
| – | – | 0.03% | 309 |
|
|
2023
Q4 | $185K | Hold |
3,000
| – | – | 0.02% | 288 |
|
|
2023
Q3 | $177K | Hold |
3,000
| – | – | 0.03% | 282 |
|
|
2023
Q2 | $179K | Buy |
+3,000
| New | +$179K | 0.02% | 281 |
|
|
2021
Q4 | – | Sell |
-30
| Closed | -$2K | – | 1055 |
|
|
2021
Q3 | $2K | Hold |
30
| – | – | ﹤0.01% | 863 |
|
|
2021
Q2 | $2K | Hold |
30
| – | – | ﹤0.01% | 691 |
|
|
2021
Q1 | $2K | Hold |
30
| – | – | ﹤0.01% | 591 |
|
|
2020
Q4 | $2K | Hold |
30
| – | – | ﹤0.01% | 600 |
|
|
2020
Q3 | $2K | Hold |
30
| – | – | ﹤0.01% | 474 |
|
|
2020
Q2 | $2K | Hold |
30
| – | – | ﹤0.01% | 520 |
|
|
2020
Q1 | $1K | Hold |
30
| – | – | ﹤0.01% | 527 |
|
|
2019
Q4 | $2K | Buy |
+30
| New | +$2K | ﹤0.01% | 504 |
|